An intermediate-effect size variant in UMOD confers risk for chronic kidney disease

Olinger, Eric; Schaeffer, Céline; Kidd, Kendrah; Elhassan, Elhussein A. E.; Cheng, Yurong; Dufour, Inès; Schiano, Guglielmo; Mabillard, Holly; Pasqualetto, Elena; Hofmann, Patrick; Fuster, Daniel G.; Kistler, Andreas D.; Wilson, Ian J.; Kmoch, Stanislav; Raymond, Laure; Robert, Thomas; Eckardt, Kai-Uwe; Bleyer, Anthony J.; Köttgen, Anna; Conlon, Peter J.; ... (2022). An intermediate-effect size variant in UMOD confers risk for chronic kidney disease. Proceedings of the National Academy of Sciences of the United States of America - PNAS, 119(33), e2114734119. National Academy of Sciences NAS 10.1073/pnas.2114734119

[img]
Preview
Text
pnas.2114734119.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (1MB) | Preview

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Nephrology and Hypertension

UniBE Contributor:

Fuster, Daniel Guido

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0027-8424

Publisher:

National Academy of Sciences NAS

Language:

English

Submitter:

Daniel Fuster

Date Deposited:

12 Aug 2022 09:11

Last Modified:

05 Dec 2022 16:22

Publisher DOI:

10.1073/pnas.2114734119

PubMed ID:

35947615

BORIS DOI:

10.48350/171869

URI:

https://boris.unibe.ch/id/eprint/171869

Actions (login required)

Edit item Edit item
Provide Feedback